DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...

The FDA has approved the latest automated artificial pancreas system from Medtronic, the MiniMed 770G, for adults and children with Type 1 diabetes as young as 2 years old. This makes the hybrid, ...

DUBLIN, Oct. 18, 2022 /PRNewswire/ -- Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G ...

Though the smallest of Medtronic’s four core businesses, the diabetes department has taken center stage as of late. Fresh off reaching a resolution with the FDA over a warning letter concerning its ...

Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 ...

Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...

A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday. Affecting all lots, serial numbers, ...

Medtronic is recalling remote controllers used with its MiniMed 508 insulin pump and MiniMed Paradigm family of insulin pumps due to dangerous security flaws. The Food and Drug Administration on ...

Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland, Oct. 4 ...

Medtronic devices comprise an estimated 60% of the insulin pump market. Image: Medtronic Medical device maker Medtronic has expanded its recall of remote controllers for its MiniMed 508 and MiniMed ...

Medtronic is urgently recalling remote controllers for insulin pumps belonging to the ‘MiniMed Paradigm’ family of products, due to severe cybersecurity risks. The controllers that should be returned ...

Medical device company Medtronic issued an urgent recall of the remote controller for certain insulin pumps because they’re vulnerable to hacks. It’s possible for someone to copy the signals sent from ...